CTOs on the Move

University of Maryland Medical System

www.umms.org

 
The University of Maryland Medical System (UMMS) is a university-based regional health care system focused on serving the health care needs of Maryland. We bring innovation, discovery and research to the care we provide all while educating the state`s future physicians and health care professionals through our partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the state, the health system`s 25,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations and at 13 hospitals. UMMS` ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.umms.org
  • 250 W. Pratt Street
    Baltimore, MD USA 21201
  • Phone: 410.328.2450

Executives

Name Title Contact Details

Similar Companies

Northeast Dental

Northeast Dental is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QR Systems Inc

QR Systems Inc is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Davis Vision Inc.

For over 35 years, Davis Vision, an award-winning specialty Vision Health Plan, has provided custom designed vision and eyecare programs to corporations, union trust funds and managed care organizations across the country.

Palisades Dental

Palisades Dental is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.